MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-10-0000204
Styrax Life Sciences Private Limited - pharma in Anakapalle, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹176.27 Cr
▲ 39% YoY
Net profit · FY 2023
₹8.32 Cr
Net margin 4.7%
EBITDA · FY 2023
₹26.97 Cr
EBITDA margin 15.3%
Authorised capital
₹16.4 Cr
Registered with MCA
Paid-up capital
₹6.57 Cr
Issued & subscribed
Open charges
₹234.22 Cr
Satisfied ₹56.92 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
202
Provident fund records
About Styrax Life Sciences Private Limited
Data last updated:
Styrax Life Sciences Private Limited is a private limited company based in Anakapalle, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2014PTC093548. Its GSTIN is 37AAFCB9406R1Z0 (Andhra Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹16.4 Cr and a paid-up capital of ₹6.57 Cr. It was formerly known as Beatus Laboratories Private Limited. It is led by directors Lakshmi Devi Suryadevara and Suryadevara Venkateswara Rao.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Anakapalle, Andhra Pradesh.
As per the financials filed for FY 2023, the company reported a revenue of ₹176.27 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹8.32 Cr (net margin 4.7%) and EBITDA of ₹26.97 Cr (EBITDA margin 15.3%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
The company has about 202 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹234.22 Cr and satisfied charges of ₹56.92 Cr on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 6 cases are pending. The company has 3 deals on record (3 funding rounds), with disclosed funding of ₹16.39 Cr; the latest was in February 2019.
Styrax Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0000204). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website styraxpharma.com.
Company details
CIN U24232AP2014PTC093548
Registration Number 093548
Incorporation Date 14 March 2014
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0000204
CIN history
Styrax Life Sciences has one previous CIN (Corporate Identification Number): U24232TG2014PTC093548. The current CIN is U24232AP2014PTC093548, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232AP2014PTC093548 | Current |
| U24232TG2014PTC093548 | Previous |
Recognitions & Rankings of Styrax Life Sciences
Contact details
Styrax Life Sciences Private Limited's registered office is in Anakapalle, Andhra Pradesh. Its website is styraxpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 5G Atchuthapuram, Rambilli Mandal Anakapalli, Anakapalle, Andhra Pradesh, India – 531061
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Styrax Life Sciences Private Limited, buy the company report.
Comprehensive company report
Styrax Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Styrax Life Sciences Private Limited
FY 2024 filings availableStyrax Life Sciences Private Limited reported revenue of ₹176.27 Cr (up 39% YoY) for FY 2023.
Revenue · FY 2023
₹176.27 Cr ▲ 39%
Net profit · FY 2023
₹8.32 Cr margin 4.7%
EBITDA · FY 2023
₹26.97 Cr margin 15.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 67%
Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 39% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹176.27 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.32 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.3% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Styrax Life Sciences Private Limited, buy the company report.
Board of directors of Styrax Life Sciences Private Limited
Styrax Life Sciences has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmi Devi Suryadevara | Director | 14 Mar 2014 | 12 Years 7 Months | Current |
| Suryadevara Venkateswara Rao | Director | 14 Mar 2014 | 12 Years 7 Months | Current |
Auditor
Styrax Life Sciences Private Limited is audited by L N P & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| L N P & Co | FY 2023 | 008918S |
Shareholding
The shareholding of Styrax Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Styrax Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹234.22 Cr
Satisfied charges
₹56.92 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2024 | 100931283 | Others | ₹20 Cr | Open | |
| 29 Mar 2024 | 100888681 | Sidbi | ₹1.65 Cr | Open | |
| 04 Oct 2023 | 100803541 | Others | ₹36 Cr | Open | |
| 30 Jun 2023 | 100742091 | Others | ₹6.87 Cr | Open | |
| 23 Mar 2023 | 100706994 | Axis Bank Limited | ₹15 Cr | Open |
To see the full charge records of Styrax Life Sciences Private Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Styrax Life Sciences Private Limited has 3 deals on record (3 funding rounds), with disclosed funding of ₹16.39 Cr; the latest was in February 2019.
Total deals
3
Funding rounds
3
Disclosed funding
₹16.39 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Funding round | ₹6.92 Cr | Investors: 2 individuals |
| Aug 2018 | Funding round | ₹2 Cr | Investors: 4 individuals |
| Aug 2018 | Funding round | ₹7.48 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Styrax Life Sciences Private Limited has 8 court cases on record: 2 filed by Styrax Life Sciences, 6 filed against it. 6 cases are pending and 2 are disposed.
Total cases
8
Filed by the company
2
Filed against the company
6
Pending
6
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 3 |
| High courts | 3 | 1 | 1 |
| Supreme Court | 2 | 2 | 2 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1901-Energy Laws - Electricity, Petroleum, Oil and Natural Gas : Energy laws - Electricity, Petroleum, Oil and Natural Gas) | Filed against the company by The State of Andhra Pradesh | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed against the company by Ms Azelis India Private Limited Through Its Authorized Representative Mr Nilesh Bhagwat Tayade | Pending |
| District court, Indore, Madhya Pradesh | Court case (UN CIV) | Filed against the company by Agarwal Coal Corporation Pvt. Ltd Through Manish | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed against the company by Greenfy India Rep.By Its Managing Partner Smt. B.Naga Subhashini | Pending |
| Supreme Court | Court case | Filed against the company by Union of India | Pending |
To see the full case history of Styrax Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Styrax Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Styrax Life Sciences Private Limited has a workforce of 202 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
202
Active EPFO establishments
1
Employee growth
9.19%
GST
Styrax Life Sciences has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCB9406R1Z0 | Andhra Pradesh | Active | 10 Nov 2017 |
| 36AAFCB9406R1Z2 | Telangana | Active | 22 Jul 2022 |
To see the full GST registrations and return filing status of Styrax Life Sciences Private Limited, buy the company report.
Recent activity
Styrax Life Sciences Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Lakshmi Devi Suryadevara was appointed as Director on 14 Mar 2014.
Charges
A charge registered on 07 Aug 2023 via Charge ID 100768693 with Others was fully satisfied on 22 Jan 2025.
Charges
A charge with Others of Rs. 20.00 Cr registered on 31 May 2024 with Charge ID 100931283 was modified on 02 Jan 2025.
Charges
A charge with Others of Rs. 36.00 Cr registered on 04 Oct 2023 with Charge ID 100803541 was modified on 10 Dec 2024.
AGM
Styrax Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 108.40 Cr registered on 27 Aug 2020 with Charge ID 100364802 was modified on 09 Jul 2024.
Charges
A charge with Others of Rs. 20.00 Cr registered on 07 Aug 2023 with Charge ID 100768693 was modified on 03 Jul 2024.
Charges
A charge with Axis Bank Limited of Rs. 15.00 Cr registered on 23 Mar 2023 with Charge ID 100706994 was modified on 03 Jul 2024.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100931283 was registered on 31 May 2024.
Filing
Styrax Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Charges
A charge with Sidbi amounted to Rs. 1.65 Cr with Charge ID 100888681 was registered on 29 Mar 2024.
Charges
A charge with Others amounted to Rs. 36.00 Cr with Charge ID 100803541 was registered on 04 Oct 2023.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100768693 was registered on 07 Aug 2023.
20 earlier events are in the company report.
Frequently asked questions
Styrax Life Sciences is an active private limited company based in Anakapalle, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 March 2014 (12+ years old) and is registered under CIN U24232AP2014PTC093548.
Styrax Life Sciences has 2 current directors:
- Lakshmi Devi Suryadevara - Director
- Suryadevara Venkateswara Rao - Director
The latest financial statements of Styrax Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Styrax Life Sciences is 37AAFCB9406R1Z0, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAFCB9406R1Z2 (Telangana).
The CIN (Corporate Identification Number) of Styrax Life Sciences is U24232AP2014PTC093548. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Styrax Life Sciences has 8 court cases on record: 2 filed by the company and 6 filed against it. 6 are pending. Most are in the district courts.
Styrax Life Sciences was incorporated on 14 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Vijayawada.
Styrax Life Sciences has 3 deals on record (3 funding rounds), with disclosed funding of ₹16.39 Cr; the latest was in February 2019.
Lakshmi Devi Suryadevara was appointed as Director on 14 Mar 2014. Suryadevara Venkateswara Rao was appointed as Director on 14 Mar 2014.
Yes, Styrax Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0000204).